ArticleThe Journal of clinical investigation2021

Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells.

Hila Shaim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.